Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats

Experimental Neurology

Volumn 232, Issue 2, 2011, Pages 299-308

  Ye, Xinchun ^a,b   Chopp, Michael ^b,c   Cui, Xu ^b   Zacharek, Alex ^b   Cui, Yisheng ^b   Yan, Tao ^b   Shehadah, Amjad ^b   Roberts, Cynthia ^b   Liu, Xinfeng ^a   Lu, Mei ^b   Chen, Jieli ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b HENRY FORD HOSPITAL   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

Angiopoietin; Niaspan; Stroke; Type one diabetes rats; Vascular remodeling

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; NICOTINIC ACID;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROVASCULAR ENDOTHELIAL CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; STROKE; TREATMENT RESPONSE;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; CHOLESTEROL, HDL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NIACIN; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 80055000205     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.09.022     Document Type: Article

References (49)

1. Adams H.P., Brott T.G., Furlan A.J., Gomez C.R., Grotta J., Helgason C.M., Kwiatkowski T., Lyden P.D., Marler J.R., Torner J., Feinberg W., Mayberg M., Thies W. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996, 94:1167-1174.
2. Alvarez-Sabin J., Molina C.A., Montaner J., Arenillas J.F., Huertas R., Ribo M., Codina A., Quintana M. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003, 34:1235-1241.
3. Arora S., Pomposelli F., LoGerfo F.W., Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J. Vasc. Surg. 2002, 35:501-505.
4. Ben-nun J., Alder V.A., Constable I.J. Retinal microvascular patency in the diabetic rat. Int. Ophthalmol. 2004, 25:187-192.
5. Calza L., Giardino L., Giuliani A., Aloe L., Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4160-4165.
6. Capes S.E., Hunt D., Malmberg K., Pathak P., Gerstein H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432.
7. Chapman M.J., Assmann G., Fruchart J.C., Shepherd J., Sirtori C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid-a position paper developed by the European Consensus Panel on HDL-C. Curr. Med. Res. Opin. 2004, 20:1253-1268.
8. Chen J.X., Stinnett A. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice. Diabetes 2008, 57:3335-3343.
9. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
10. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
11. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 2003, 92:692-699.
12. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., Zhang C., Lu M., Katakowski M., Feldkamp C.S., Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 2003, 53:743-751.
13. Chen J., Cui X., Zacharek A., Jiang H., Roberts C., Zhang C., Lu M., Kapke A., Feldkamp C.S., Chopp M. Niaspan increases angiogenesis and improves functional recovery after stroke. Ann. Neurol. 2007, 62:49-58.
14. Chen J., Cui X., Zacharek A., Chopp M. Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J. Cell. Mol. Med. 2009, 13:1348-1357.
15. Cui X., Chopp M., Zacharek A., Ye X., Roberts C., Chen J. Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol. Dis. 2011, 43:285-292.
16. Elam M.B., Hunninghake D.B., Davis K.B., Garg R., Johnson C., Egan D., Kostis J.B., Sheps D.S., Brinton E.A. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial. JAMA 2000, 284:1263-1270.
17. Ergul A., Elgebaly M.M., Middlemore M.L., Li W., Elewa H., Switzer J.A., Hall C., Kozak A., Fagan S.C. Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol. 2007, 7:33.
18. Hershey J.C., Baskin E.P., Glass J.D., Hartman H.A., Gilberto D.B., Rogers I.T., Cook J.J. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc. Res. 2001, 49:618-625.
19. Ho T.K., Rajkumar V., Black C.M., Abraham D.J., Baker D.M. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischaemia. Br. J. Surg. 2006, 93:1368-1376.
20. Hoffman W.H., Litaker M.S., Pluta R.M., Camens M.L. Cerebral vasoreactivity in children and adolescents with type 1 diabetes mellitus. Endocr. Res. 2004, 30:315-325.
21. Hori S., Ohtsuki S., Hosoya K., Nakashima E., Terasaki T. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J. Neurochem. 2004, 89:503-513.
22. Hughes S., Gardiner T., Hu P., Baxter L., Rosinova E., Chan-Ling T. Altered pericyte-endothelial relations in the rat retina during aging: implications for vessel stability. Neurobiol. Aging 2006, 27:1838-1847.
23. Iurlaro M., Scatena M., Zhu W.H., Fogel E., Wieting S.L., Nicosia R.F. Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins. J. Cell Sci. 2003, 116:3635-3643.
24. Lee J.M., Zhai G., Liu Q., Gonzales E.R., Yin K., Yan P., Hsu C.Y., Vo K.D., Lin W. Vascular permeability precedes spontaneous intracerebral hemorrhage in stroke-prone spontaneously hypertensive rats. Stroke 2007, 38:3289-3291.
25. Li Y., Jiang N., Powers C., Chopp M. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 1998, 29:1972-1980. (discussion 1980-1971).
26. Li W., Prakash R., Kelly-Cobbs A.I., Ogbi S., Kozak A., El-Remessy A.B., Schreihofer D.A., Fagan S.C., Ergul A. Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes 2010, 59:228-235.
27. Mark K.S., Davis T.P. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1485-H1494.
28. Mast H., Thompson J.L., Lee S.H., Mohr J.P., Sacco R.L. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. Stroke 1995, 26:30-33.
29. Mayranpaa M., Simpanen J., Hess M.W., Werkkala K., Kovanen P.T. Arterial endothelial denudation by intraluminal use of papaverine-NaCl solution in coronary bypass surgery. Eur. J. Cardiothorac. Surg. 2004, 25:560-566.
30. Metheny-Barlow L.J., Tian S., Hayes A.J., Li L.Y. Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF. Microvasc. Res. 2004, 68:221-230.
31. Morris D.C., Chopp M., Zhang L., Lu M., Zhang Z.G. Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke. Neuroscience 2010, 169:674-682.
32. Nourhaghighi N., Teichert-Kuliszewska K., Davis J., Stewart D.J., Nag S. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab. Invest. 2003, 83:1211-1222.
33. Pfister F., Feng Y., vom Hagen F., Hoffmann S., Molema G., Hillebrands J.L., Shani M., Deutsch U., Hammes H.P. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008, 57:2495-2502.
34. Pfister F., Wang Y., Schreiter K., vom Hagen F., Altvater K., Hoffmann S., Deutsch U., Hammes H.P., Feng Y. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol. 2010, 47:59-64.
35. Poppe A.Y., Majumdar S.R., Jeerakathil T., Ghali W., Buchan A.M., Hill M.D. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009, 32:617-622.
36. Rikitake Y., Hirata K., Kawashima S., Ozaki M., Takahashi T., Ogawa W., Inoue N., Yokoyama M. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2002, 22:108-114.
37. Rosell A., Cuadrado E., Ortega-Aznar A., Hernandez-Guillamon M., Lo E.H., Montaner J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 2008, 39:1121-1126.
38. Sandhu R., Teichert-Kuliszewska K., Nag S., Proteau G., Robb M.J., Campbell A.I., Kuliszewski M.A., Kutryk M.J., Stewart D.J. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Cardiovasc. Res. 2004, 64:115-124.
39. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74.
40. Shehadah A., Chen J., Cui X., Roberts C., Lu M., Chopp M. Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome. J. Neurol. Sci. 2010, 294:107-111.
41. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
42. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N., Yancopoulos G.D. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282:468-471.
43. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 1990, 10:290-293.
44. Ye X., Chopp M., Liu X., Zacharek A., Cui X., Yan T., Roberts C., Chen J. Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats. Neuroscience 2011, 190:339-345.
45. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 2003, 112:1533-1540.
46. Zhang Z., Chopp M., Zhang R.L., Goussev A. A mouse model of embolic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1997, 17:1081-1088.
47. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 2000, 106:829-838.
48. Zhang Z.G., Zhang L., Yepes M., Jiang Q., Li Q., Arniego P., Coleman T.A., Lawrence D.A., Chopp M. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 2002, 106:740-745.
49. Zhang Z.G., Zhang L., Croll S.D., Chopp M. Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience 2002, 113:683-687.